期刊文献+

人巨细胞病毒IgG抗体质控盘的建立 被引量:4

The establishment of human cytomegalovirus IgG quality control panel
下载PDF
导出
摘要 目的建立人巨细胞病毒IgG抗体质控盘,为以酶联免疫法和化学发光法为原理的人巨细胞病毒IgG抗体诊断试剂盒的性能评价提供可靠的质控物质。方法通过试剂盒筛选出人巨细胞病毒IgG抗体的阳性和阴性血清,将10份不同来源的阳性血清作为质控盘的P1~P10,5份不同来源的阴性血清作为质控盘的N1~N5,5份阳性血清混合制成质控盘的L1~L3。之后,用不同的试剂盒验证建立的质控盘。结果六家公司的试剂盒对本质控盘进行的准确性、特异性和检测限的验证结果均符合要求。对本质控盘的稳定性研究结果表明,质控盘的稳定性良好。成功建立了人巨细胞病毒IgG抗体质控盘。结论本研究建立的质控盘可用于以酶联免疫法和化学发光法等原理的人巨细胞病毒IgG抗体诊断试剂盒的性能评价。 Objective To establish the control panel for human cytomegalovirus IgG antibody detection kits,providing reliable control materials for the quality evaluations of these enzyme-linked immunosorbent or chemiluminescence based kits. Methods The positive and negative serums were selected by kits. The P1~P10 of the control panel were produced by 10 different sources of positive serums. The N1~N5 of the control panel were produced by 5 different sources of negative serums. The L1~L3 were produced by the mixture of 5 different sources of positive serums. Then,the control panels were verified . Results The results of accuracy, specificity, and detectability verified by detection kits of six different companies matched the requirements. The research of stability indicated these panels were stable enough. The control panels were established successfully. Conclusion The control panel is suitable for the quality evaluations of most human cytomegalovirus IgG detection kits,which are based on the principle of enzyme-linked immunosorbent assay and chemiluminescence ect.
出处 《分子诊断与治疗杂志》 2012年第5期308-313,共6页 Journal of Molecular Diagnostics and Therapy
基金 国家"863"计划(2011AA02115) 国家科技部项目(2011604)
关键词 人巨细胞病毒 IGG抗体 质控盘 Human cytomegalovirus IgG antibody Quality control panel
  • 相关文献

参考文献3

二级参考文献20

  • 1侯林浦,姜英涛,高英,张萌,马旭.巨细胞病毒IgG抗体亲和指数测定的方法及临床意义[J].中华临床医学荟萃杂志,2004,1(1):14-17. 被引量:5
  • 2侯林浦,马旭.做好预防出生缺陷工作[J].中国计划生育学杂志,2005,13(10):582-583. 被引量:6
  • 3闻良珍,吴圣楣,吕绳敏,王志新,曾万江,钱小虎,敖黎明,刘兰青,凌霞珍.三城市孕妇人巨细胞病毒感染及其母婴传播的流行病学调查[J].中华妇产科杂志,1996,31(12):714-717. 被引量:114
  • 4Andersen H, Brostrom K, Hansen HB, et al. A prospective study on the incidence and significance of congenital cytomegalovirus infection [ J ]. Acta Paediatr Scand, 1979,68 ( 3 ) : 329-336.
  • 5Staras SA, Dollard SC, Radford KW, et al. Seroprevalcnce of cytomegalovirus infection in the United States, 1988-1994 [ J ]. Clin Infect Dis ,2006,43 : 1143.
  • 6Pannuti CS, Vilas Boas LS, Angelo M J, et al. Cytomegalovirus mononucleosis in children and adults: differences in clinical presentation[ J]. Scand .J Infect Dis, 1985,17 : 153-156.
  • 7Sohn YM, Park KI, Lee C, et al. Congenital cytomegalovirus infection in Korean population with very high prevalence of maternal immunity[ J]. J Kor Med Sci, 1992,7:47-51.
  • 8Kenneson A,Cannon MJ. Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection [ J ]. Rev Med Virol,2007 ,17 :253.
  • 9Fowler KB, Stagno S, Pass RF, et al. The outcome of congenital cytomegalovirus infection in relation to maternal antibody status [J]. N Engl J Med,1992,326(10) :663-667.
  • 10Blackburn NK, Besselaar TG,Schoub BD, et al. Differentiation of primary cytomegalovims infection from reactivation using the urea denaturation test for measuring antibody avidity [ J ]. J Med Virol,1991,33( 1 ) :6-9.

共引文献13

同被引文献54

  • 1孙立山,周文达.人巨细胞病毒感染的实验室诊断研究进展[J].检验医学,2005,20(3):284-286. 被引量:7
  • 2侯林浦,马旭.做好预防出生缺陷工作[J].中国计划生育学杂志,2005,13(10):582-583. 被引量:6
  • 3王露楠,邓巍,张瑞,申子瑜,陈文祥,李金明.乙型肝炎表面抗原血清标准物质的研究[J].中华检验医学杂志,2007,30(8):858-862. 被引量:13
  • 4中华医学会儿科学分会感染消化学组.巨细胞病毒感染诊断方案.中国实用儿科杂志,2000,15(2):121-121.
  • 5Staras S A, Dollard S C, Radford K W, et al. Seroprevalcnce of cy-tomegalovirus infection in the United States, 1988-1994 [ J ]. Clin Infect Dis, 2006, 35(43) : 1143-1148.
  • 6Grangeot-Keros L, Cointe D. Diagnosis and prognostic markers of HCMV infection[ J]. J Clin Virol,2001,21 (3) :213-221.
  • 7Weber B, Berger A, Rabenau H. Human cytomegalovirus infec- tion : diagnostic potential of recombinant antigens for cytomegalovir- us antibody detection [ J]. J Virol Methods ,2001,96 (2) : 157-170.
  • 8国家质量监督检验检疫总局,国家标准化委员会.体外诊断医疗器械生物源性样品中量的测量校准品和质控物质赋值的计量学溯源性[s].中华人民共和国国家标准:GB/T21415-2008/ISO17511:2003.
  • 9国家食品药品监督管理总局.体外诊断试剂注册管理办法[S/0L].(2014-06-27)[2014-10-15].http://WWW.sda.gov.en/WSO1/CIl0053/103757html.
  • 10The European Parliament and The Council of the EU. In vitro diagnostic medical devices [S:. Directive 98 ! 79 ! EC of the European Parliament and the Council, 1998.

引证文献4

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部